Organisation paid for research Program year 2024 Source: CMS Open Payments

Boise Kidney & Hypertension

Neither a doctor nor a teaching hospital

Research payments

$246,516

126 payments

Through program year 2024, Boise Kidney & Hypertension is reported as receiving $246,516 in research payments, across 126 payments.

By program year

5 rows
Year Kind Amount Payments
2024 Research $65,914 19
2023 Research $21,995 14
2021 Research $49,056 32
2020 Research $43,948 32
2019 Research $65,603 29

Breakdown

Who paid Research payments · program years 2019–2024
  1. Retrophin, Inc. $234,460 125 payments
  2. Otsuka Pharmaceutical Development & Commercialization, Inc. $12,056 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. 021Igan17001 $128,544 85 payments
  2. 021Fsgs16010 $58,252 32 payments
  3. Spartacus $41,067 4 payments
  4. A Phase 3B, Multi-Center, Open-Label Trial to Evaluate the Long Term Safety of Titrated Immediate-Release Tolvaptan Opc-41061, 30 MG to 120 Mgday, Split Dose in Subjects With Autosomal Dominant Polycystic Kidney Disease $12,056 1 payment
  5. A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy (PROTECT) $4,945 3 payments
  6. Clinical Trial Payments for Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS) (DUPLEX) $1,652 1 payment
What the money was spent on Research payments · program years 2019–2024
  1. Other $114,999 78 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record